Infantile Hemangioma: An Updated Review.
Leung AKC, Lam JM, Leong KF, Hon KL.
Curr Pediatr Rev. 2021;17(1):55-69. doi: 10.2174/1573396316666200508100038.
Infantile haemangioma.
Léauté-Labrèze C, Harper JI, Hoeger PH.
Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13.
Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC, Modiri O, England RW, Shawber CJ, Wu JK.
Plast Reconstr Surg. 2021 Apr 1;147(4):875-885. doi: 10.1097/PRS.0000000000007699.
Successful treatment of infantile hemangioma with high risk of severe sequelae by microneedle radiofrequency.
Qiu Y, Qiao C, Yang J, Gao W, Lin X.
Dermatol Ther. 2020 Nov;33(6):e13953. doi: 10.1111/dth.13953. Epub 2020 Aug 11.
Propranolol for severe hemangiomas of infancy.
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A.
N Engl J Med. 2008 Jun 12;358(24):2649-51. doi: 10.1056/NEJMc0708819.
Our experience with propranolol for infantile hemangioma.
Wu Y, Zhao P, Song W, Lu W, Dai T, Wang L.
Skin Res Technol. 2023 Apr;29(4):e13310. doi: 10.1111/srt.13310.
Oral atenolol compared to oral propranolol for infantile hemangioma.
Meza Viteri V, Aranibar L.
Medwave. 2023 Dec 7;23(11):e2753. doi: 10.5867/medwave.2023.11.2753.
Is Infantile Hemangioma a Neuroendocrine Tumor?
Kaulanjan-Checkmodine P, Oucherif S, Prey S, Gontier E, Lacomme S, Loot M, Miljkovic-Licina M, Cario M, Léauté-Labrèze C, Taieb A, Moisan F, Rezvani HR.
Int J Mol Sci. 2022 May 5;23(9):5140. doi: 10.3390/ijms23095140.
Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls.
Tiemann L, Hein S.
J Pediatr Pharmacol Ther. 2020;25(7):586-599. doi: 10.5863/1551-6776-25.7.586.
Safety of Propranolol Therapy for Severe Infantile Hemangioma.
Prey S, Voisard JJ, Delarue A, Lebbe G, Taïeb A, Leaute-Labreze C, Ezzedine K.
JAMA. 2016 Jan 26;315(4):413-5. doi: 10.1001/jama.2015.13969.
